Hair loss leads UK scalp care coverage as minoxidil search interest holds

Analysis

Hair loss, rather than flakes or itch, is driving UK scalp-care conversation this week. Google Trends shows 'minoxidil' averaging 64/100 search interest in the UK over the last three months, sitting at 50/100 in the week of 28 September ^[1] — far ahead of 'dandruff shampoo' at an average of 12/100 (11/100 that week) ^[2] and 'hair loss treatment' at an average of 8/100 (5/100 that week) ^[3]. The implication for retailers and brands is that shoppers are searching by active ingredient rather than by category, so product discovery is happening at molecule level.

Editorial supply is matching that demand. British Vogue has run an expert-recommended shampoo round-up framed around hair loss ^[4], Glamour UK has published a first-person test of hair growth vitamins ^[5], and InStyle has covered a growth serum recommended by Dakota Johnson's hairstylist, credited with stopping hormonal shedding ^[6]. Clinical and explanatory coverage is running alongside: Medscape has surveyed treatments from minoxidil through to transplant surgery ^[7], Mount Sinai Today has addressed how consumers can tell whether their shedding is alopecia ^[8], and The Guardian has examined whether GLP-1 use causes significant hair loss ^[9] — a question worth tracking given the UK's weight-loss medication boom.

Two further signals. Forbes argues female hair loss remains common but privately experienced ^[10], echoed by a Rooted in Confidence hair loss workshop for women run via Newry, Mourne and Down District Council ^[11]. Nature has published research linking sympathetic nerve activity to autoimmune hair loss susceptibility ^[12]. Finally, a safety flag: Vet Times reports a cat poison warning over a hair loss treatment ^[13] — relevant to household-safety messaging.